Chronic Kidney Disease Management in the Middle East and Africa: Concerns, Challenges, and Novel Approaches

References

• Kaze AD, Ilori T, Jaar BG, et al. Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis. BMC Nephrol. 2018;19:125. doi:10.1186/s12882-018-0930-5
   PubMed Web of Science ®Google Scholar
• Bikbov B, Purcell CA, Levey AS; GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709–733. doi:10.1016/S0140-6736(20)30045-3
   PubMed Web of Science ®Google Scholar
• Malekmakan L, Tadayon T, Roozbeh J, et al. End-stage renal disease in the middle east: a systematic review and meta-analysis. Iran J Kidney Dis. 2018;12:195–203.
   PubMed Web of Science ®Google Scholar
• Richards N, Hassan M, Saleh AK, et al. Epidemiology and referral patterns of patients with chronic kidney disease in the Emirate of Abu Dhabi. Saudi J Kidney Dis Transpl. 2015;26:1028–1034. doi:10.4103/1319-2442.164600
   PubMedGoogle Scholar
• Kazancioglu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl. 2013;3:368–371. doi:10.1038/kisup.2013.79
   PubMed Web of Science ®Google Scholar
• Farag YM, Al Wakeel JS. Diabetic nephropathy in the Arab Gulf countries. Nephron Clin Pract. 2011;119:c317–c322. doi:10.1159/000328909
   PubMedGoogle Scholar
• AlSahow A. Demographics and key clinical characteristics of hemodialysis patients from the gulf cooperation council (GCC) participating in DOPPS. Nephrol Dialysis Transplant. 2016;31:i279–i297. doi:10.1093/ndt/gfw175.29
   Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3:1–150.
   Web of Science ®Google Scholar
• Al-Shamsi S, Regmi D, Govender RD, Cheng X. Chronic kidney disease in patients at high risk of cardiovascular disease in the United Arab Emirates: a population-based study. PLoS One. 2018;13:e0199920. doi:10.1371/journal.pone.0199920
   PubMedGoogle Scholar
• Feehally J, Khosravi M. Effects of acute and chronic hypohydration on kidney health and function. Nutr Rev. 2015;73:110–119. doi:10.1093/nutrit/nuv046
   PubMed Web of Science ®Google Scholar
• Ameh OI, Ekrikpo UE, Kengne AP. Preventing CKD in low- and middle-income countries: a call for urgent action. Kidney Int Rep. 2019;5:255–262. doi:10.1016/j.ekir.2019.12.013
   PubMed Web of Science ®Google Scholar
• Bello AK, Alrukhaimi M, Ashuntantang GE, et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl. 2017;7:122–129. doi:10.1016/j.kisu.2017.07.007
   Web of Science ®Google Scholar
• Shaheen FA, Souqiyyeh MZ. Kidney health in the Middle East. Clin Nephrol. 2010;74:S85–S88. doi:10.5414/cnp74s085
   PubMed Web of Science ®Google Scholar
• Farag YMK, Kari JA, Singh AK. Chronic kidney disease in the Arab world: a call for action. Nephron Clin Pract. 2013;121:c120–c123. doi:10.1159/000345149
   Google Scholar
• Ameh OI, Ekrikpo U, Bello A, et al. Current management strategies of chronic kidney disease in resource-limited countries. Int J Nephrol Renovasc Dis. 2020;13:239–251. doi:10.2147/IJNRD.S242235
   PubMed Web of Science ®Google Scholar
• Lo C, Teede H, Fulcher G, et al. Gaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: a cross-sectional study. BMC Nephrol. 2017;18:80. doi:10.1186/s12882-017-0493-x
   PubMed Web of Science ®Google Scholar
• Jardine MJ, Kasiske B, Adu D, et al. Closing the gap between evidence and practice in chronic kidney disease. Kidney Int Suppl. 2017;7:114–121. doi:10.1016/j.kisu.2017.07.006
   Web of Science ®Google Scholar
• Razavian M, Heeley EL, Perkovic V, et al. Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). Nephrol Dial Transplant. 2012;27:1396–1402. doi:10.1093/ndt/gfr599
   PubMed Web of Science ®Google Scholar
• Yacoub R, Campbell KN. Inhibition of RAS in diabetic nephropathy. Int J Nephrol Renovasc Dis. 2015;8:29–40. doi:10.2147/IJNRD.S37893
   PubMed Web of Science ®Google Scholar
• Al Attar B. Renal replacement therapy in the Kingdom of Saudi Arabia. Saudi J Kidney Dis Transpl. 2020;31:1458–1469. doi:10.4103/1319-2442.308375
   PubMed Web of Science ®Google Scholar
• Nagata D, Hishida E, Masuda T. Practical strategy for treating chronic kidney disease (CKD)-associated with hypertension. Int J Nephrol Renovasc Dis. 2020;13:171–178. doi:10.2147/IJNRD.S259931
   PubMed Web of Science ®Google Scholar
• Breyer MD, Susztak K. Developing treatments for chronic kidney disease in the 21st century. Semin Nephrol. 2016;36:436–447. doi:10.1016/j.semnephrol.2016.08.001
   PubMed Web of Science ®Google Scholar
• Cherney DZI, Bakris GL. Novel therapies for diabetic kidney disease. Kidney Int Suppl. 2018;8:18–25. doi:10.1016/j.kisu.2017.10.005
   Web of Science ®Google Scholar
• Bakris GL, Agarwal R, Anker SD, et al.; FIDELIO-DKD Investigators. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383:2219–2229. doi:10.1056/NEJMoa2025845
   PubMed Web of Science ®Google Scholar
• Górriz JL, Soler MJ, Navarro-González JF, et al. GLP-1 receptor agonists and diabetic kidney disease: a call of attention to nephrologists. J Clin Med. 2020;9:947. doi:10.3390/jcm9040947
   PubMed Web of Science ®Google Scholar
• Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al.; DAPA-CKD Trial Committees and Investigators. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383:1436–1446. doi:10.1056/NEJMoa2024816
   PubMed Web of Science ®Google Scholar
• Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380:347–357. doi:10.1056/NEJMoa1812389
   PubMed Web of Science ®Google Scholar
• McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381:1995. doi:10.1056/NEJMoa1911303
   PubMed Web of Science ®Google Scholar
• Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. N Engl J Med 2016; 375: 323334.; 375: 323334.
   Google Scholar
• Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and Cardiovascular and Renal Event in Type 2 Diabetes. N Engl J Med 2017; 377: 644657.; 377: 644657.
   Google Scholar
• Mosenzon O, Wiviott SD, Cahn A. et al. Effect of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes. Lancet Diabetes Endocrinol 2019; 7: 60617.; 7: 60617.
   Web of Science ®Google Scholar
• Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019;380:22952306. doi: 2019;380:22952306. doi: 10.1056/NEJMoa1811744
   Google Scholar
• Giugliano D, Esposito K. Class effect for SGLT-2 inhibitors: a tale of 9 drugs. Cardiovasc Diabetol. 2019;18:94. doi:10.1186/s12933-019-0899-9
   PubMed Web of Science ®Google Scholar
• Molina P, Gavela E, Vizcaíno B, Huarte E, Carrero JJ. Optimizing Diet to Slow CKD Progression. Front Med. 2021;8:654250. doi:10.3389/fmed.2021.654250
   Web of Science ®Google Scholar
• Cupisti A, Giannese D, Moriconi D, D’Alessandro C, Torreggiani M, Piccoli GB. Nephroprotection by SGLT2i in CKD patients: may it be modulated by low-protein plant-based diets? Front Med. 2020;7:622593. doi:10.3389/fmed.2020.622593
   Web of Science ®Google Scholar
• de Boer IH, Caramori ML, Chan JCN, et al. Executive summary of the 2020 KDIGO diabetes management in CKD guideline: evidence-based advances in monitoring and treatment. Kidney Int. 2020;98:839–848. doi:10.1016/j.kint.2020.06.024
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2020;98:S1–S15. doi:10.1016/j.kint.2020.06.019
   PubMed Web of Science ®Google Scholar